With the focus on next generation bioprocessing, it is important that manufacturers do not forget to re-examine their approach to viral safety.

Step into the design space and your life will be changed forever.

Tony Hitchcock discusses his career and the evolution of the gene therapy market.

Elsevier aims to help protect patients against adverse drug reactions with its updated drug-drug interaction calculator.

What challenges are companies facing in the post-FMD climate?

Can bacterial viruses improve drug delivery to the brain?

Denis Hunn from ystral takes us inside the world of the mixer, highlighting how technologies have changed over the years.

Sitting Down With... Chip Davis, President and CEO of the Association for Accessible Medicines (AAM).

Brexit is a serious challenge for UK businesses trading with the EU.

Pharma companies have been raising awareness for years, but patients continue to buy counterfeit medicines online.